$RNGE 5 SEC Filings

Filed On	Filing
31 Mar 2023	Form 5: Celeste Richard F, Director Granted 250,000 Stock Option (Right to Buy)
31 Mar 2023	Form 5: Zipp Brandon Joel, Chief Science Officer Granted 250,000 Stock Option (Right to Buy)
31 Mar 2023	Form 5: Cavanaugh Michael R., Chief Executive Officer Granted 750,000 Stock Option (Right to Buy)
31 Mar 2023	Form 5: Feighan Edward F, Director Granted 250,000 Stock Option (Right to Buy)
31 Mar 2023	Form 5: Mckilligan Richard, Chief Financial Officer Granted 250,000 Stock Option (Right to Buy)
13 May 2013	Form 5: Maida Anthony E Iii, Director Received 100,000 shares as a grant or award

Comments